California Public Employees Retirement System Athira Pharma, Inc. Transaction History

California Public Employees Retirement System

$147 Billion
Q4 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$10.24 - $20.87 $264,089 - $538,237	-25,790 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$16.9 - $29.77 $41,033 - $72,281	-2,428 Reduced 8.6%	25,790 $475,000
Q4 2020 Feb 02, 2021	BUY	$16.48 - $34.3 $465,032 - $967,877	28,218 New	28,218 $966,000

Others Institutions Holding ATHA

# of Institutions

Shares Held

19M

Call Options Held

23.6K

Put Options Held

68K

Perceptive Advisors LLC New York, NY

5.4M
Shares

$2.54 Million
0.11% of portfolio
Bml Capital Management, LLC Zionsville, IN

2.78M
Shares

$1.3 Million
1.01% of portfolio
Vanguard Group Inc Valley Forge, PA

1.56M
Shares

$731,625
0.0% of portfolio
Simplify Asset Management Inc. New York, NY

1.49M
Shares

$701,612
0.05% of portfolio
Propel Bio Management, LLC Los Angeles, CA

1.49M
Shares

$701,612
0.87% of portfolio

View Full List

About Athira Pharma, Inc.

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $17.8M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

More about ATHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account